Logo1
ICCS - International Clinical Cytometry Society Annual Course and Meeting 2022
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV/technology.
Quality of facilities and facility accommodations.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
Objective 1: Understand the scientific basis of clinical flow cytometry and its applications in the diagnosis of hematologic disease.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
Objective 2: Become familiar with the latest technical advances in flow cytometry that can be applied in their own laboratories.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
Did this program improve your Skill or Strategy in your role or contribution as a member of the healthcare team?
If no, why not?
Do you believe your participation in this activity will positively impact your healthcare team?
If yes, how?
If no, why not?
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor used technology effectively
Describe the utility of flow cytometry in the diagnosis of benign and malignant hematolymphoid disorders
Recognize the components of a flow cytometer
Describe an approach to panel design for a flow cytometry assay and what elements should be considered
Discuss the purpose and fundamentals of method validation for flow cytometry assays (both qualitative and quantitative)
Identify recommended data sets for each validation parameter along with statistical examples
The instructor used technology effectively
Define factors that are taken into account to determine validation strategies
Define assay-specific points for validation, including the conversion from an IVD to an LDT
Discuss procedural, quality assurance, and QC issues related to the validation of a quasi-quantitative flow cytometry assay
Discuss procedural, quality assurance, and QC issues related to the validation of a qualitative flow cytometry assay
Review diagnostic pitfalls in flow cytometry data analysis and strategies for troubleshooting artifacts and potential errors in flow cytometry data
The instructor used technology effectively
Recognize normal myeloid and lymphoid populations and their maturation patterns by flow cytometry
Describe the expression patterns of normal cells in different hematologic organs
The instructor used technology effectively
Identify normal and abnormal B cell populations and discuss the utility of flow cytometry in the classification of B cell lymphomas
Use flow cytometry data to diagnose and classify cases of acute lymphoblastic leukemia and acute myeloid leukemia
Recognize unusual phenotypic variants of B cell neoplasms
Describe pitfalls in the routine diagnosis of acute lymphoblastic leukemia
Distinguish mixed phenotype acute leukemias from acute lymphoblastic leukemia
The instructor used technology effectively
Recognize normal components of bone marrow on bivariate dot plots of flow cytometry data
Use software to analyze fcs files of flow cytometry data to diagnose cases of acute leukemia and lymphoma based on patterns of antigen expression
Distinguish abnormal from normal populations on flow cytometry plots of CD45 vs side scatter
Describe the value of color gating in the analysis of flow cytometry data
The instructor used technology effectively
Describe the utility of flow cytometry in the diagnosis of chronic myeloid stem cell neoplasms
Identify characteristic immunophenotypic features of chronic myeloid neoplasms
Describe the methodological principles of minimal residual disease testing in leukemia
Discuss the general strategy for MRD assessment post therapy and post targeted therapy
The instructor used technology effectively
Identify T and NK cells by flow cytometry and recognize normal antigen expression
Identify aberrant plasma cell populations and use flow cytometry to classify plasma cell neoplasms
Recognize phenotypic aberrancies that can help to identify and classify abnormal T and NK cells by flow cytometry
Review potential pitfalls in the analysis of CD4+ T cell absolute counts and identify strategies for troubleshooting artifacts and potential errors
The instructor used technology effectively
improve lab efficiency by implemmeting sample processing automation in clinical laboratory
introduce spectral flow cytometry and its potentials in clinical aplication
update and summary of the status and progress of AI in clinical flow cytometry
Improve data analysis by introducing automation
The instructor used technology effectively
Overview of flow cytometry applications in the diagnosis, screening and monitoring of patients with Germline Predisposition
Provide an updates on mixed phenotype of acute leukemia, the genetics, classification and relevance to flow cytometry immunophenotyping
Review and update on Flow Cytometry Applications in the Diagnosis snd Managemnet Of Immunodeficiency Disorders
The instructor used technology effectively
Overview the methology and principles of the complex yet much demanded AML minimal residual disease flow cytometry assay; illustrate the challenges and provide solutions in data interpretation using case examples
The instructor used technology effectively
Overview the flow cytometry applcations in the diagnosis and differential diagnosis of rare disorders of eosinophils, mast cell, basophils and plasmacytoid dendritic cells. Discuss technical consideration and data interpretations using case illustrations
The instructor used technology effectively
Navigate the document of CLSI H62 with flow cytomtriests. Highlight and interpret the critical elements in assay validation, instruments standarlization and optimization
The instructor used technology effectively
Discuss different methods for sample processing and staining, provide tips on improving light-chain resolution; optimal preservation, handling and maximizing yields of paucicellular specimens (e.g., CSF); tissue disaggregation, cocktail preparation and QC, antibody titration and lot-to-lot QC. Improve the preanalytic quality and provide high quality assays and data
The instructor used technology effectively
Review College of American Pathologists Accreditation FLOW Checklist Items focusing on new items and updates
Discuss the EU Regulation on In Vitro Diagnostic Medical Devices 2017/746 (IVDR), and requirement for flow cytomterists
Review the process and requirement for FDA IDE approval for complex assays such as AML MRD
The instructor used technology effectively
Learn normal myeloid maturation patterns and identify abnormalities and cell origins in the diagnosis and differential diagnosis of myeloid neoplasms
Learn the normal phenotypes of monocytes and dendritic cells and identify abnormalities and cell origins in the diagnosis and differential diagnosis of monocytic leukemia and dendritic cell neoplasms
Learn erythroid maturation patterns and identify abnormalities and cell origins in the diagnosis of myeloid neoplasms
The instructor used technology effectively
Overview the flow cytometry applications in the diagnosis and follow-up including MRD detection of T-lymphoblastic leukemia. Introduce different methods in assay set up, and approaches in data interpretion with case illustration
The instructor used technology effectively
Illustrate the need for clinical flow cytometry lab to support clinical trials and biomarker research. Understand the requirement and differences from CLIA assays
The instructor used technology effectively
Interpret CLSI H62 assay validations using one qualitative and one quantitative assay validation example by medical directors. The workshop will facilitate the understanding of the principles and various elements in assay validations
The instructor used technology effectively
Address the issues related to instrumentation, including how to set up the instrument, creating and checking compensation, carryover testing, maintenance, and troubleshooting. Improve the preanalytic quality and provide high quality assays and data
The instructor used technology effectively
provide an updates on B-lymphoblastic leukemia, the genetics, classification and relevance to flow cytometry immunophenotyping
provide an updates on mixed phenotype of acute leukemia, the genetics, classification and relevance to flow cytometry immunophenotyping
review recent updates on genomic characerization of MPAL and ETP
Please tell us about any sessions you found particularly good or bad.
Please tell us about any objectives you feel we accomplished well or poorly.
Please tell us about any presenters you found particularly good or bad.
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):
How much did you learn as a result of this education program?
What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments:

Mr question
Provided by amedco